Free Trial

Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by D. E. Shaw & Co. Inc.

Addus HomeCare logo with Medical background

D. E. Shaw & Co. Inc. lessened its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 25.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 70,556 shares of the company's stock after selling 24,569 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.39% of Addus HomeCare worth $8,844,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of ADUS. Dimensional Fund Advisors LP lifted its holdings in shares of Addus HomeCare by 1.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock worth $86,833,000 after acquiring an additional 10,434 shares during the last quarter. Capital Research Global Investors purchased a new stake in Addus HomeCare in the 4th quarter worth about $51,149,000. TimesSquare Capital Management LLC lifted its stake in Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock worth $44,593,000 after purchasing an additional 78,835 shares during the last quarter. Invesco Ltd. boosted its position in shares of Addus HomeCare by 6.5% during the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company's stock valued at $43,386,000 after buying an additional 21,266 shares during the period. Finally, Northern Trust Corp lifted its stake in shares of Addus HomeCare by 3.3% during the 4th quarter. Northern Trust Corp now owns 285,872 shares of the company's stock worth $35,834,000 after acquiring an additional 9,122 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Stephens restated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie increased their target price on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $142.57.

Check Out Our Latest Stock Analysis on ADUS

Addus HomeCare Stock Up 0.6%

Shares of ADUS traded up $0.71 during mid-day trading on Tuesday, hitting $111.80. 25,238 shares of the company traded hands, compared to its average volume of 165,024. The business has a 50 day moving average of $100.66 and a 200 day moving average of $113.56. The company has a market capitalization of $2.06 billion, a PE ratio of 25.58, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.21 earnings per share. As a group, research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines